| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.22 | 1e-09 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.23 | 1e-05 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.18 | 7e-05 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.2 | 9e-05 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0002 |